Zimmer Biomet
ZBH | NYSE
$101.41
-$1.80 (-1.74%)
At close: Nov 16, 2026, 4:00 PM ET
$101.41
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 5:35 PM ET
Zimmer Biomet Company Profile
Company profile explainedCompany Profile
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Key Executives
| Name | Position |
|---|---|
| Ivan Tornos | President, Chief Executive Officer & Chairman of the Board |
| Angela Main | Senior Vice President, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific |
| Chad F. Phipps | Senior VP, Chief Legal & Corporate Affairs Officer and Secretary |
| David DeMartino | Senior Vice President of Investor Relations |
| JehanZeb Noor | Senior VP, Chief Strategy, Business Development, Innovation & Transformation Officer |
| Jonathan Vigdorchik | Chief Science, Technology & Medical Affairs Officer |
| Kevin R. Thornal | Group President of Global Businesses & Americas |
| Kristen Cardillo | Senior Vice President & Chief Communications Officer |
| Paul A. Stellato | Interim CFO, VP, Controller & Chief Accounting Officer |
| Shaun Braun | Senior Vice President & Chief Information and Technology Officer |
| Wilfred van Zuilen | Group President of Europe, Middle East & Africa |
Zimmer Biomet
| Country | United States |
| IPO Date | Jul 25, 2001 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 17,000 |
| CEO | Ivan Tornos |
Contact Details
345 East Main Street Warsaw,
Indiana 46580 United States
Stock Details
| Ticker Symbol | ZBH |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001136869 |
| CUSIP Number | 98956P102 |
| ISIN Number | US98956P1021 |
| SIC Code | 3842 |
Recent News
- 8 days ago / marketbeat.comWhat Zimmer Biomet (ZBH) Said on Its Q3 Earnings Call
- 11 days ago / prnewswire.comZimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery
- 12 days ago / zacks.comWhy Zimmer Biomet (ZBH) is a Top Momentum Stock for the Long-Term
- 13 days ago / benzinga.comZimmer Biomet Lifts Annual Growth Despite Challenging Knee Market
- 13 days ago / seekingalpha.comZimmer Biomet Holdings, Inc. (ZBH) Q3 2026 Earnings Call Transcript
- 13 days ago / zacks.comZimmer Biomet Stock Up on Q3 Earnings & Revenue Beat, '26 View Up
- 13 days ago / zacks.comZimmer (ZBH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- 13 days ago / zacks.comZimmer Biomet (ZBH) Q3 Earnings and Revenues Beat Estimates
- 13 days ago / prnewswire.comZimmer Biomet Announces Third Quarter 2026 Financial Results
- 19 days ago / zacks.comZimmer Biomet Gears Up to Report Q3 Earnings: What's in the Cards?
Add to Watchlist
Select watchlists to add or remove ZBH